EQS-News

MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT increases to 30.2 million euros.

EQS-News: MPH Health Care AG / Key word(s): Preliminary Results/Annual Results MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT increases to 30.2 million euros. 25.04.2024 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. MPH Health Care AG: Preliminary IFRS result 2023

Equity (net asset value) increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT increases to 30.2 million euros. The equity ratio rises to 94.2%.

Berlin, 25 April 2024 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated result for the 2023 financial year. Accordingly, equity increased from EUR 221.4 million to EUR 251.0 million. The net asset value (NAV) per share rose by 13.3% from EUR 51.72 (31 December 2022) to EUR 58.62 as of
31 December 2023.

In the 2023 financial year, preliminary EBIT totalled EUR 30.2 million (previous year: EUR 29.6 million) and the IFRS net profit for the year was EUR 29.5 million (previous year: EUR 29.1 million). As of 31 December 2023, equity increased by EUR 29.6 million to EUR 251.0 million (previous year: EUR 221.4 million). The equity ratio rose to 94.2% (previous year: 93.4%) and remains at a very high level.

MPH AG is an investment company whose investments are recognised as financial assets under the balance sheet item "Financial assets" and are measured at fair value through profit or loss as at the balance sheet date. The net profit for the year is mainly the result of the fair value measurement of the listed investments held as at the balance sheet date, resulting from the higher market prices of the investments compared to the previous year's balance sheet date. 

The investments M1 Kliniken AG and CR Energy AG, which are listed on the Frankfurt Stock Exchange, were operationally successful in 2023.

In the past financial year 2023, M1 Kliniken AG further expanded its market position in the field of cosmetic medicine and opened four new specialist medical centres in Germany and abroad. With the opening of the Bucharest and Sofia locations, the expansion in Eastern Europe, whose target markets are considered lucrative by the company, will continue. Sales in the "Beauty" segment rose by 18% to EUR 70.8 million (previous year: EUR 60.2 million). The EBIT margin in this segment increased from 11.7% in the previous year to 21.9%.